Powered by Topple

Rand Paul says Biden admin antibody distribution mirrors socialism

Powered by Topple

Get the latest BPR news delivered free to your inbox daily. SIGN UP HERE


CHECK OUT WeThePeople.store for best SWAG!

The Biden administration’s plans to redistribute Regeneron’s monoclonal-antibody treatment in a way that’s “equitable” is another perfect example of how socialism functions, according to Kentucky Sen. Rand Paul.

Speaking on Fox News’ “Hannity” late Friday, he noted that in a true capitalist society, monoclonal antibodies would be distributed based on need, not so-called “equity.”

“This is the difference between socialized medicine and capitalism. Under capitalism, when there’s increased demand — and Florida has increased demand right now — you increase the supply. Supply matches demand in capitalism,” he said.

“In socialism, you have political reasons. So it could be that they think there are more deplorable people in Florida, more Republicans or more of the unvaccinated unwashed. And so decisions will be made for political reasons,” he added.

Which is exactly what appears to be happening — and, in fact, has been happening for months now.

Listen to Paul’s remarks below:

(Video: Fox News)

Only two months ago, Democrats and their media allies were relentlessly targeting Florida Gov. Ron DeSantis for promoting monoclonal antibodies.

First, they claimed the antibodies didn’t work. Then they claimed that the antibodies worked but shouldn’t be promoted because only the coronavirus vaccine deserves that honor. And, most recently, they accused the governor of promoting monoclonal antibodies on behalf of a top donor.

Note that these are the same outlets that made an issue out of the governor prioritizing the distribution of vaccines to the elderly.

Then all of a sudden the narrative changed and this week Democrats and their media allies began essentially accusing DeSantis of hoarding all the monoclonal antibodies.

Because of this hoarding, they argued, it’s now necessary for the Biden administration to take control of the nation’s monoclonal antibodies supply and begin distributing the supply as it sees fit.

“The policy change that went into effect Monday is all but certain to result in cuts of the medication to some states, especially seven in the Deep South with high infection rates that have been using about 70 percent of the national supply,” The Washington Post reported Tuesday.

In other words, the administration intends to cut the supply of monoclonal antibodies going to the Republican-led states that have been using this treatment because of high demand, and redistribute the supply to blue states.

DeSantis has made it clear he won’t tolerate this.

“I will fight like hell to overcome Biden’s cruel decision to drastically reduce life-saving monoclonal antibody treatments for Floridians. We’ve seen steep reductions in hospital admissions due to early treatment efforts. It’s wrong to penalize Florida for his partisan bitterness,” the governor said Thursday.

The belief that the administration’s move is rooted entirely in politics isn’t shared by just him.

This move goes against not only the marketplace but also the science. According to University of Alabama at Birmingham professor Dr. Turner Overton, the antibodies reduce the risk of hospitalization by 70 percent in high-risk unvaccinated people.

“Monoclonal antibodies are supplemental antibodies that can be administered early in the course of infection — the first 10 days after symptoms commence — to rapidly bind and kill the COVID virus. This infusion can be lifesaving if given in the first 10 days of symptoms,” she told the university’s news portal, UAB News, last month.

In other words, the vaccinated don’t really need monoclonal antibodies, and this is relevant because the most vaccinated states are blue states.

Continuing his remarks on Fox News, Paul pointed out that “if this were capitalism, and this were going out into the marketplace, the companies would be ramping up production and it would be distributed where it’s needed.”

Versus where it’s so-called “equitable” and/or politically convenient.

In a sane world, according to Paul, the administration would not only reverse course but also change its recommendations regarding the use of monoclonal antibodies.

The current recommendations coming from Dr. Anthony Fauci and the CDC don’t allow in-patient coronavirus patients or those who’ve experienced symptoms for more than 10 days to take the antibodies.

“You can be an in-patient with relatively good oxygenation – talking, not yet on a ventilator – but they won’t give it to you if you’ve gotten beyond 10 days of symptoms or if you’re an in-patient,” he said.

“You could have four days of symptoms, be put in a hospital. You still meet the criteria as far as symptoms, but once you cross the threshold from the ER into the hospital, they deny you treatment,” he added.

The administration’s policies seem to make no logical or scientific sense. The only time they do make sense, it appears, is when they’re viewed through the lens of partisan Democrat-styled politics …

Vivek Saxena

Comments

Latest Articles